Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL.

Bouwstra R, He Y, de Boer J, Kooistra H, Cendrowicz E, Fehrmann RSN, Ammatuna E, Zu Eulenburg C, Nijland M, Huls G, Bremer E, van Meerten T.

Cancer Immunol Res. 2019 Aug 13. doi: 10.1158/2326-6066.CIR-18-0781. [Epub ahead of print]

PMID:
31409608
2.

Molecular markers of prognosis in canine cortisol-secreting adrenocortical tumours.

Sanders K, van Staalduinen GJ, Uijens MCM, Mol JA, Teske E, Slob A, Hesselink JW, Kooistra HS, Galac S.

Vet Comp Oncol. 2019 Jul 13. doi: 10.1111/vco.12521. [Epub ahead of print]

PMID:
31301217
3.

Redox unbalance in the hyperthyroid cat: a comparison with healthy and non-thyroidal diseased cats.

Candellone A, Gianella P, Ceccarelli L, Raviri G, Badino P, Roncone S, Kooistra HS, Meineri G.

BMC Vet Res. 2019 May 8;15(1):136. doi: 10.1186/s12917-019-1896-7.

4.

The Utrecht Score: A novel histopathological scoring system to assess the prognosis of dogs with cortisol-secreting adrenocortical tumours.

Sanders K, Cirkel K, Grinwis GCM, Teske E, van Nimwegen SA, Mol JA, Hesselink JW, Kooistra HS, Galac S.

Vet Comp Oncol. 2019 Sep;17(3):329-337. doi: 10.1111/vco.12474. Epub 2019 Apr 7.

PMID:
30860644
5.

Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well-controlled patients on VKA for atrial fibrillation: a randomised controlled trial (GAInN).

van Miert JHA, Kooistra HAM, Veeger NJGM, Westerterp A, Piersma-Wichers M, Meijer K.

Br J Haematol. 2019 Aug;186(3):e21-e23. doi: 10.1111/bjh.15856. Epub 2019 Mar 6. No abstract available.

PMID:
30843186
6.

Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.

Yata M, Kooistra HS, Beijerink NJ.

J Vet Intern Med. 2019 Mar;33(2):462-470. doi: 10.1111/jvim.15416. Epub 2019 Jan 31.

7.

Concurrent pituitary and adrenocortical lesions on computed tomography imaging in dogs with spontaneous hypercortisolism.

van Bokhorst KL, Kooistra HS, Boroffka SAEB, Galac S.

J Vet Intern Med. 2019 Jan;33(1):72-78. doi: 10.1111/jvim.15378. Epub 2018 Dec 11.

8.

Behavior in dogs with spontaneous hypothyroidism during treatment with levothyroxine.

Hrovat A, De Keuster T, Kooistra HS, Duchateau L, Oyama MA, Peremans K, Daminet S.

J Vet Intern Med. 2019 Jan;33(1):64-71. doi: 10.1111/jvim.15342. Epub 2018 Nov 30.

9.

TRH-induced secretion of adrenocorticotropin and cortisol in dogs with pituitary-dependent hypercortisolism.

Pijnacker T, Knies M, Galac S, Sanders K, Mol JA, Kooistra HS.

Vet Q. 2018 Dec;38(1):72-78. doi: 10.1080/01652176.2018.1521537.

PMID:
30362899
10.

Treating canine Cushing's syndrome: Current options and future prospects.

Sanders K, Kooistra HS, Galac S.

Vet J. 2018 Nov;241:42-51. doi: 10.1016/j.tvjl.2018.09.014. Epub 2018 Sep 27. Review.

PMID:
30340659
11.

Abiraterone Acetate for Cushing Syndrome: Study in a Canine Primary Adrenocortical Cell Culture Model.

Sanders K, de Wit WL, Mol JA, Kurlbaum M, Kendl S, Kroiss M, Kooistra HS, Galac S.

Endocrinology. 2018 Nov 1;159(11):3689-3698. doi: 10.1210/en.2018-00588.

PMID:
30219917
12.

Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies.

Sanders K, Mol JA, Kooistra HS, Galac S.

Vet Res Commun. 2018 Dec;42(4):283-288. doi: 10.1007/s11259-018-9737-x. Epub 2018 Sep 5.

13.

Use of basal and TRH-stimulated plasma growth hormone concentrations to differentiate between primary hypothyroidism and nonthyroidal illness in dogs.

Pijnacker T, Kooistra HS, Vermeulen CF, van der Vinne M, Prins M, Galac S, Mol JA.

J Vet Intern Med. 2018 Jul;32(4):1319-1324. doi: 10.1111/jvim.15139. Epub 2018 May 7.

14.

Steroidogenic factor-1 inverse agonists as a treatment option for canine hypercortisolism: in vitro study.

Sanders K, Mol JA, Slob A, Kooistra HS, Galac S.

Domest Anim Endocrinol. 2018 Apr;63:23-30. doi: 10.1016/j.domaniend.2017.11.001. Epub 2017 Nov 21.

PMID:
29223003
15.

Prolactinoma in a Dog.

Cosio C, Sartori E, Garatti M, Luccardini L, Grinwis GCM, Kooistra HS, Fracassi F.

Vet Pathol. 2017 Nov;54(6):972-976. doi: 10.1177/0300985817726118. Epub 2017 Aug 16.

PMID:
28812531
16.

In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation.

Albers-Wolthers CHJ, de Gier J, Walen M, van Kooten PJS, Lambalk CB, Leegwater PAJ, Roelen BAJ, Schaefers-Okkens AC, Rutten VPMG, Millar RPM, Kooistra HS.

PLoS One. 2017 Jun 26;12(6):e0179156. doi: 10.1371/journal.pone.0179156. eCollection 2017.

17.

Acromegaly in a non-diabetic cat.

Fracassi F, Salsi M, Sammartano F, Bo S, Kooistra HS.

JFMS Open Rep. 2016 Apr 25;2(1):2055116916646585. doi: 10.1177/2055116916646585. eCollection 2016 Jan-Jun.

18.

Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinoma.

van der Boom T, Klein Hesselink EN, Kooistra HAM, Meijer K, van der Horst-Schrivers ANA, Lefrandt JD, Links TP.

Endocr Relat Cancer. 2017 Jun;24(6):267-273. doi: 10.1530/ERC-17-0013.

PMID:
28476911
19.

Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands.

Schaefer S, Kooistra HS, Riond B, Suchodolski JS, Steiner JM, Prins M, Zini E, Reusch CE.

J Feline Med Surg. 2017 Aug;19(8):888-896. doi: 10.1177/1098612X16664390. Epub 2016 Aug 30.

PMID:
27578200
20.

The Influence of Pituitary Size on Outcome After Transsphenoidal Hypophysectomy in a Large Cohort of Dogs with Pituitary-Dependent Hypercortisolism.

van Rijn SJ, Galac S, Tryfonidou MA, Hesselink JW, Penning LC, Kooistra HS, Meij BP.

J Vet Intern Med. 2016 Jul;30(4):989-95. doi: 10.1111/jvim.14367. Epub 2016 Jul 18.

21.

Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists.

Kooistra HA, Calf AH, Piersma-Wichers M, Kluin-Nelemans HC, Izaks GJ, Veeger NJ, Meijer K.

JAMA Intern Med. 2016 Aug 1;176(8):1176-83. doi: 10.1001/jamainternmed.2016.3057.

PMID:
27379731
22.

Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients.

Kooistra HA, Piersma-Wichers M, Kluin-Nelemans HC, Veeger NJ, Meijer K.

Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):388-94. doi: 10.1161/CIRCOUTCOMES.115.002612. Epub 2016 Jun 21.

PMID:
27329860
23.

Validation of a noninvasive diagnostic tool to verify neuter status in dogs: The urinary FSH to creatinine ratio.

Albers-Wolthers CH, de Gier J, Oei CH, Schaefers-Okkens AC, Kooistra HS.

Theriogenology. 2016 Sep 15;86(5):1376-81. doi: 10.1016/j.theriogenology.2016.04.081. Epub 2016 May 6.

PMID:
27242177
24.

New Insights in the Functional Zonation of the Canine Adrenal Cortex.

Sanders K, Mol JA, Kooistra HS, Slob A, Galac S.

J Vet Intern Med. 2016 May;30(3):741-50. doi: 10.1111/jvim.13946. Epub 2016 Apr 25.

25.

The effects of kisspeptin agonist canine KP-10 and kisspeptin antagonist p271 on plasma LH concentrations during different stages of the estrous cycle and anestrus in the bitch.

Albers-Wolthers CH, de Gier J, Rutten VP, van Kooten PJ, Leegwater PA, Schaefers-Okkens AC, Kooistra HS.

Theriogenology. 2016 Jul 15;86(2):589-95. doi: 10.1016/j.theriogenology.2016.02.009. Epub 2016 Feb 23.

PMID:
27020879
26.

Central Hypothyroidism in Miniature Schnauzers.

Voorbij AM, Leegwater PA, Buijtels JJ, Daminet S, Kooistra HS.

J Vet Intern Med. 2016 Jan-Feb;30(1):85-91. doi: 10.1111/jvim.13818. Epub 2015 Dec 23.

27.

Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.

Kooistra HA, Gebel M, Sahin K, Lensing AW, Meijer K.

Thromb Haemost. 2015 Nov 25;114(6):1136-43. doi: 10.1160/TH14-12-1033. Epub 2015 Jul 30.

PMID:
26224199
28.

Expression of somatostatin, dopamine, progesterone and growth hormone receptor mRNA in canine cortisol-secreting adrenocortical tumours.

Kool MM, Galac S, van der Helm N, Spandauw CG, Kooistra HS, Mol JA.

Vet J. 2015 Oct;206(1):108-10. doi: 10.1016/j.tvjl.2015.05.014. Epub 2015 May 27.

PMID:
26143682
29.

The prognostic value of perioperative profiles of ACTH and cortisol for recurrence after transsphenoidal hypophysectomy in dogs with corticotroph adenomas.

van Rijn SJ, Hanson JM, Zierikzee D, Kooistra HS, Penning LC, Tryfonidou MA, Meij BP.

J Vet Intern Med. 2015 May-Jun;29(3):869-76. doi: 10.1111/jvim.12601. Epub 2015 May 8.

30.

Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors.

Kool MM, Galac S, van der Helm N, Corradini S, Kooistra HS, Mol JA.

J Vet Intern Med. 2015 Jan;29(1):214-24. doi: 10.1111/jvim.12528.

31.

Atlanto-axial malformation and instability in dogs with pituitary dwarfism due to an LHX3 mutation.

Voorbij AM, Meij BP, van Bruggen LW, Grinwis GC, Stassen QE, Kooistra HS.

J Vet Intern Med. 2015 Jan;29(1):207-13. doi: 10.1111/jvim.12523. Epub 2015 Jan 14.

32.

Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.

Kooistra HA, Veeger NJ, Khorsand N, Kluin-Nelemans HC, Meijer K, Piersma-Wichers M.

Thromb Haemost. 2015 Apr;113(4):881-90. doi: 10.1160/TH14-06-0537. Epub 2014 Dec 18. Erratum in: Thromb Haemost. 2015 Aug 31;114(3):656.

PMID:
25518854
33.

A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy.

Khorsand N, Kooistra HA, van Hest RM, Veeger NJ, Meijer K.

Thromb Res. 2015 Jan;135(1):9-19. doi: 10.1016/j.thromres.2014.11.019. Epub 2014 Nov 22. Review.

PMID:
25480313
34.

Feline hyperthyroidism: a common disorder with unknown pathogenesis.

Kooistra HS.

Vet Rec. 2014 Nov 8;175(18):456-7. doi: 10.1136/vr.g6597. No abstract available.

PMID:
25377207
35.

Pituitary dwarfism in Saarloos and Czechoslovakian wolfdogs is associated with a mutation in LHX3.

Voorbij AM, Leegwater PA, Kooistra HS.

J Vet Intern Med. 2014 Nov-Dec;28(6):1770-4. doi: 10.1111/jvim.12448. Epub 2014 Oct 1.

36.

Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma.

Campos M, Ducatelle R, Rutteman G, Kooistra HS, Duchateau L, de Rooster H, Peremans K, Daminet S.

J Vet Intern Med. 2014 Nov-Dec;28(6):1805-13. doi: 10.1111/jvim.12436. Epub 2014 Sep 24.

37.

Upregulation of the PI3K/Akt pathway in the tumorigenesis of canine thyroid carcinoma.

Campos M, Kool MM, Daminet S, Ducatelle R, Rutteman G, Kooistra HS, Galac S, Mol JA.

J Vet Intern Med. 2014 Nov-Dec;28(6):1814-23. doi: 10.1111/jvim.12435. Epub 2014 Sep 17.

38.

Expression of steroidogenic factor 1 in canine cortisol-secreting adrenocortical tumors and normal adrenals.

Galac S, Kool MM, van den Berg MF, Mol JA, Kooistra HS.

Domest Anim Endocrinol. 2014 Oct;49:1-5. doi: 10.1016/j.domaniend.2014.04.002. Epub 2014 Apr 28.

PMID:
25010021
39.

Identification of a novel kisspeptin with high gonadotrophin stimulatory activity in the dog.

Albers-Wolthers KH, de Gier J, Kooistra HS, Rutten VP, van Kooten PJ, de Graaf JJ, Leegwater PA, Millar RP, Schaefers-Okkens AC.

Neuroendocrinology. 2014;99(3-4):178-89. doi: 10.1159/000364877. Epub 2014 Jun 5.

PMID:
24902774
40.

Pharmacokinetics of total thyroxine after repeated oral administration of levothyroxine solution and its clinical efficacy in hypothyroid dogs.

van Dijl IC, Le Traon G, van de Meulengraaf BD, Burgaud S, Horspool LJ, Kooistra HS.

J Vet Intern Med. 2014 Jul-Aug;28(4):1229-34. doi: 10.1111/jvim.12363. Epub 2014 Apr 28.

41.

Splenectomy and second malignancies in patients with Hodgkin lymphoma.

Kooistra HA, Kluin-Nelemans HC, van Imhoff GW, van Dijk BA, de Bock GH, van der Kaaij MA.

Leuk Lymphoma. 2015 Jan;56(1):230-1. doi: 10.3109/10428194.2014.910658. Epub 2014 May 12. No abstract available.

PMID:
24707939
42.

Evaluation of the oral fludrocortisone suppression test for diagnosing primary hyperaldosteronism in cats.

Djajadiningrat-Laanen SC, Galac, Boevé MH, Boroffka SA, Naan EC, IJzer J, Kooistra HS.

J Vet Intern Med. 2013 Nov-Dec;27(6):1493-9.

43.

Immunohistochemical expression of potential therapeutic targets in canine thyroid carcinoma.

Campos M, Ducatelle R, Kooistra HS, Rutteman G, Duchateau L, Polis I, Daminet S.

J Vet Intern Med. 2014 Mar-Apr;28(2):564-70. doi: 10.1111/jvim.12330. Epub 2014 Feb 24.

44.

Expression of angiogenesis-related genes in canine cortisol-secreting adrenocortical tumors.

Kool MM, Galac S, Kooistra HS, Mol JA.

Domest Anim Endocrinol. 2014 Apr;47:73-82. doi: 10.1016/j.domaniend.2013.11.004. Epub 2013 Nov 16.

PMID:
24377872
45.

Best practice for the pharmacological management of hyperthyroid cats with antithyroid drugs.

Daminet S, Kooistra HS, Fracassi F, Graham PA, Hibbert A, Lloret A, Mooney CT, Neiger R, Rosenberg D, Syme HM, Villard I, Williams G.

J Small Anim Pract. 2014 Jan;55(1):4-13. doi: 10.1111/jsap.12157. Epub 2013 Dec 27. Review. Erratum in: J Small Anim Pract. 2014 Mar;55(3):179.

PMID:
24372075
46.

Effects of an iodine-restricted food on client-owned cats with hyperthyroidism.

van der Kooij M, Bečvářová I, Meyer HP, Teske E, Kooistra HS.

J Feline Med Surg. 2014 Jun;16(6):491-8. doi: 10.1177/1098612X13512627. Epub 2013 Nov 14.

PMID:
24232246
47.

Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.

Kool MM, Galac S, Spandauw CG, Kooistra HS, Mol JA.

J Vet Intern Med. 2013 Nov-Dec;27(6):1486-92. doi: 10.1111/jvim.12194. Epub 2013 Sep 20.

48.

Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal).

Behrend EN, Kooistra HS, Nelson R, Reusch CE, Scott-Moncrieff JC.

J Vet Intern Med. 2013 Nov-Dec;27(6):1292-304. doi: 10.1111/jvim.12192. Epub 2013 Sep 20.

49.

Progesterone receptor isoforms in the mammary gland of cats and dogs.

Gracanin A, de Gier J, Zegers K, Bominaar M, Rutteman GR, Schaefers-Okkens AC, Kooistra HS, Mol JA.

Reprod Domest Anim. 2012 Dec;47 Suppl 6:313-7. doi: 10.1111/rda.12045.

PMID:
23279527
50.

Disorders of sexual development and associated changes in the pituitary-gonadal axis in dogs.

Buijtels JJ, de Gier J, Kooistra HS, Grinwis GC, Naan EC, Zijlstra C, Okkens AC.

Theriogenology. 2012 Oct 15;78(7):1618-26. doi: 10.1016/j.theriogenology.2012.07.010.

PMID:
22980090

Supplemental Content

Loading ...
Support Center